Statistics
Publications
13
Citations
740
H-Index
12
Active since
1991
Bob Amess is an author at University of Cambridge specializing in life sciences, biochemistry, and molecular biology.
Publications per year
1991–2023
13
13
Proteomics: a major new technology for the drug discovery process
Martin Pagé, Bob Amess, Christian Rohlff et al. · Drug Discovery Today · 1999 · 76 citations
Tumor monocyte content predicts immunochemotherapy outcomes in esophageal adenocarcinoma
Joseph A. Chadwick, Richard Owen, Michael J. White et al. · Cancer Cell · 2023 · 51 citations · Full text
Life Sciences, Immunology, Oncology +17
1–5 of 13